DOCU, BRQS, PETZ, PALT, TCRT: Trending Stocks Today 10 June

By Kirsteen Mackay

Published:

In this article

  • Loading...
  • Want to see what you should be buying? Check out our top picks.

Stocks trending today include Docusign (DOCU), Borqs Tech (BRQS), TDH Holdings (PETZ), Paltalk (PALT), and Alaunos Therapeutics (TCRT).

DOCU, BRQS, PETZ, PALT, TCRT: Trending Stocks Today 10 June

S&P futures were little changed in Friday morning trading after US equities came under pressure on Thursday, with the S&P, Nasdaq and Russell down more than 2%. Stocks are currently on track for significant weekly losses.

Investors eagerly await news of the May CPI data, which could influence Fed guidance next week. 

Oil up, gold flat and Bitcoin (BTC) down.

Here are some of today’s trending stocks: 

Docusign Inc (NASDAQ: DOCU)

Docusign Inc (NASDAQ: DOCU) stock is down nearly 25% after its Q1 2023 earnings call. DocuSign, Inc. provides cloud-based electronic signature solutions. 

Q1 Highlights

  • Total revenue: $589m (up 25% Y/Y)

  • International revenue: up 43% Y/Y

  • Billings: up 16%

  • Added nearly 67,000 new customers (up 25%) total to 1.24 million paying customers

Unfortunately, the business is facing inflationary concerns, a volatile workforce environment and general global instability. Therefore, the company’s revenue growth rates are slowing, and the path to profitability is elusive. 

Over the past year, Docusign Inc (DOCU) has traded between $64.84 and $314.76. Today, it sits around $66.

Borqs Technologies Inc (NASDAQ: BRQS)

The Borqs Technologies Inc (NASDAQ: BRQS) share price is up 32.7% in pre-market trading after rising 3% in Thursday’s session.

Borqs Technologies, Inc. is a global provider of embedded software and products for the Internet of Things (IoT), providing customizable, differentiated and scalable Android-based smart-connected mobile devices and E2E cloud-service solutions. It engages in the development of android platform solutions, hardware products, and mobile virtual network operator services.

A couple of days ago, the company announced its solar energy subsidiary, Holu Hou Energy, will play a significant role in the Battery Bonus Program introduced by Hawaiian Electric Company. The program was announced in July 2021 for customers on Oahu. It will be utilized to assist HECO in meeting the electricity need of residents during high load periods of the day.

Over the past year, Borqs Technologies Inc (BRQS) has traded between $0.14 and $1.60. Pre-market it is around $0.22.

TDH Holdings Inc (NASDAQ: PETZ)

TDH Holdings Inc (NASDAQ: PETZ) manufactures and distributes pet food products.

Investors are discussing TDH Holdings Inc (PETZ) on Friday, after the company’s stock climbed by 28.05% during Thursday's session to settle at $0.28. It is up a further 15% in pre-market trading to $0.32.

On 9 Jun '22, TDH Holding (PETZ-US) closed at USD 0.28, -96.0% off its 52-week high vs. the subsector average change of -24.4%.

Paltalk Inc (NASDAQ: PALT)

Paltalk Inc (NASDAQ: PALT) stock is up over 33% in pre-market trading. The optimism comes after Paltalk announced it had acquired the core assets of ManyCam from Visicom Media Inc. ManyCam is a live streaming software and a virtual camera that allows users to deliver professional live videos on any streaming platform video conferencing app or distance learning tool.

Paltalk develops communications software to enhance multimedia communication and data transmission security and privacy solutions.

Over the past year, Paltalk Inc (PALT) has traded between $1.76 and $15.20. In pre-market trading, it sits around $2.59.

Alaunos Therapeutics Inc (NASDAQ: TCRT)

Investors are discussing Alaunos Therapeutics Inc (NASDAQ: TCRT) on Friday, after the company’s stock climbed by 12.29% during Thursday's session to settle at $0.85. The TCRT share price is up a further 30% in pre-market trading. 

This penny biotech stock is being discussed on social media and trading channels but does not appear to have announced anything newsworthy.

Alaunos Therapeutics is a clinical-stage oncology-focused cell therapy company. 

Explore more on these topics:

Share:

IMPORTANT NOTICE AND DISCLAIMER

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

Kirsteen Mackay does not hold any position in the stock(s) and/or financial instrument(s) mentioned in the above article.

Kirsteen Mackay has not been paid to produce this piece by the company or companies mentioned above.

Digitonic Ltd, the owner of ValueTheMarkets.com, does not hold a position or positions in the stock(s) and/or financial instrument(s) mentioned in the above article.

Digitonic Ltd, the owner of ValueTheMarkets.com, has not been paid for the production of this piece by the company or companies mentioned above.

Sign up for Investing Intel Newsletter